Follow
Xavier Vila-Farrés
Xavier Vila-Farrés
Director of Research (Contrafect)
Verified email at contrafect.com
Title
Cited by
Cited by
Year
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace
I Roca, P Espinal, X Vila-Farrés, J Vila
Frontiers in microbiology 3, 148, 2012
4752012
Commensal bacteria make GPCR ligands that mimic human signalling molecules
LJ Cohen, D Esterhazy, SH Kim, C Lemetre, RR Aguilar, EA Gordon, ...
Nature 549 (7670), 48-53, 2017
4062017
Discovery of MRSA active antibiotics using primary sequence from the human microbiome
J Chu, X Vila-Farres, D Inoyama, M Ternei, LJ Cohen, EA Gordon, ...
Nature Chemical Biology 12 (12), 1004-1006, 2016
1832016
A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity
F Rabanal, A Grau-Campistany, X Vila-Farrés, J Gonzalez-Linares, ...
Scientific reports 5 (1), 10558, 2015
972015
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii
X Vila-Farres, CG De La Maria, R López-Rojas, J Pachón, E Giralt, J Vila
Clinical Microbiology and Infection 18 (4), 383-387, 2012
932012
Insights into templated supramolecular polymerization: binding of naphthalene derivatives to ssDNA templates of different lengths
PGA Janssen, S Jabbari-Farouji, M Surin, X Vila, JC Gielen, TFA de Greef, ...
Journal of the American Chemical Society 131 (3), 1222-1231, 2009
922009
Chemical synthesis, 3D structure, and ASIC binding site of the toxin mambalgin‐2
CI Schroeder, LD Rash, X Vila‐Farrés, KJ Rosengren, M Mobli, GF King, ...
Angewandte Chemie International Edition 53 (4), 1017-1020, 2014
792014
Combating virulence of Gram-negative bacilli by OmpA inhibition
X Vila-Farrés, R Parra-Millán, V Sánchez-Encinales, M Varese, ...
Scientific reports 7 (1), 14683, 2017
692017
The outer membrane porin OmpW of Acinetobacter baumannii is involved in iron uptake and colistin binding
M Catel‐Ferreira, S Marti, L Guillon, L Jara, G Coadou, V Molle, ...
FEBS letters 590 (2), 224-231, 2016
632016
Early In Vitro and In Vivo Development of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to Daptomycin
C García-de-la-Mària, JM Pericas, A Del Río, X Castañeda, X Vila-Farrés, ...
Antimicrobial agents and chemotherapy 57 (5), 2319-2325, 2013
592013
Antimicrobials inspired by nonribosomal peptide synthetase gene clusters
X Vila-Farres, J Chu, D Inoyama, MA Ternei, C Lemetre, LJ Cohen, ...
Journal of the American Chemical Society 139 (4), 1404-1407, 2017
582017
Update of peptides with antibacterial activity
X Vila-Farres, E Giralt, J Vila
Current medicinal chemistry 19 (36), 6188-6198, 2012
422012
Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group
JM Conlon, A Sonnevend, T Pál, X Vila-Farrés
International journal of antimicrobial agents 39 (4), 317-320, 2012
412012
Solid phase synthesis of peptide-selenoesters
A Ghassemian, X Vila-Farrés, PF Alewood, T Durek
Bioorganic & medicinal chemistry 21 (12), 3473-3478, 2013
382013
Synthetic-bioinformatic natural product antibiotics with diverse modes of action
J Chu, B Koirala, N Forelli, X Vila-Farres, MA Ternei, T Ali, DA Colosimo, ...
Journal of the American Chemical Society 142 (33), 14158-14168, 2020
362020
CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates
X Vila-Farrés, AE Callarisa, X Gu, PB Savage, E Giralt, J Vila
International journal of antimicrobial agents 46 (5), 568-571, 2015
352015
Bioactive synthetic-bioinformatic natural product cyclic peptides inspired by nonribosomal peptide synthetase gene clusters from the human microbiome
J Chu, X Vila-Farres, SF Brady
Journal of the American Chemical Society 141 (40), 15737-15741, 2019
342019
Human Microbiome Inspired Antibiotics with Improved β-Lactam Synergy against MDR Staphylococcus aureus
J Chu, X Vila-Farres, D Inoyama, R Gallardo-Macias, M Jaskowski, ...
ACS infectious diseases 4 (1), 33-38, 2018
342018
Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy
R Parra-Millán, X Vila-Farrés, R Ayerbe-Algaba, M Varese, ...
Journal of Antimicrobial Chemotherapy 73 (12), 3405-3412, 2018
332018
Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro
X Vila-Farrés, M Ferrer-Navarro, AE Callarisa, S Martí, P Espinal, S Gupta, ...
Journal of Antimicrobial Chemotherapy 70 (11), 2981-2986, 2015
332015
The system can't perform the operation now. Try again later.
Articles 1–20